Short- and mid-term outcomes of abdominoperineal resection with perineal mesh insertion: a single-centre experience

Ahmed Gendia1, Masood Rehman2, Cindy W Lin2

  • 1Colorectal Department, Northampton University Hospital, Northampton, NN1 5BD, UK. ahmed.gendia@nhs.net.

Insights

Biological mesh closure after abdominoperineal resection (APR) for low rectal cancer shows favorable short-term outcomes. This technique helps manage challenging perineal wounds, reducing complications like hernias and improving overall survival.

Area of Science:

  • Surgical Oncology
  • Colorectal Surgery
  • Wound Management

Background:

  • Abdominoperineal resection (APR) is crucial for low rectal/anorectal cancers.
  • Perineal wound closure, especially after extralevator APR (ELAPR), presents significant challenges due to tissue gaps.
  • Various methods are explored to enhance perineal wound repair outcomes.

Purpose of the Study:

  • To evaluate the 6-year experience with biological mesh for perineal wound closure following APR.
  • To assess the efficacy and safety of biological mesh in managing complex perineal defects.

Main Methods:

  • Retrospective analysis of a prospectively maintained database from 2016-2021.
  • Inclusion of patients who underwent APR with perineal mesh closure.
  • Data collection on patient demographics, surgical approach, neoadjuvant therapy, outcomes, and follow-up.

Main Results:

  • 49 patients underwent APR with perineal mesh reconstruction; 63% male, mean age 68, mean BMI 27.9.
  • 30% perineal wound infection rate; 4.1% perineal hernia rate.
  • 91% overall survival; 18.3% disease recurrence rate over a mean follow-up of 29.2 months.

Conclusions:

  • Routine use of biological mesh for perineal wound closure after APR demonstrates favorable short- and medium-term outcomes.
  • The technique appears effective in managing complex perineal defects, contributing to good oncological and survival results.
Abstract